Literature DB >> 1131359

Anomaly in visual acuity testing in children.

R M Youngson.   

Abstract

A popular and widely used method of visual acuity testing of young children is criticized on the grounds that it often fails to elicit amblyopia. The results obtained when the visual acuity of thirty amblyopic children was tested by different methods show that monotype testing gives an apparent acuity averaging three grades better than those derived from the standard Snellen's test.

Entities:  

Mesh:

Year:  1975        PMID: 1131359      PMCID: PMC1017375          DOI: 10.1136/bjo.59.3.168

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  [Modern treatment of strabismus].

Authors:  C CUPPERS
Journal:  Klin Monbl Augenheilkd Augenarztl Fortbild       Date:  1956

2.  Visual acuity testing in young children.

Authors:  C G Keith; Z Diamond; A Stansfield
Journal:  Br J Ophthalmol       Date:  1972-11       Impact factor: 4.638

3.  Pitfalls in testing children's vision by the Sheridan Gardiner single optotype method.

Authors:  A F Hilton; J C Stanley
Journal:  Br J Ophthalmol       Date:  1972-02       Impact factor: 4.638

4.  Picture cube for vision screening of pre-school children.

Authors:  S W Hyams; E Neumann
Journal:  Br J Ophthalmol       Date:  1972-07       Impact factor: 4.638

  4 in total
  4 in total

1.  Preschool vision screening: negative predictive value for amblyopia.

Authors:  D K Newman; M M East
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

2.  Screening for amblyopia: a comparison of paediatric letter tests.

Authors:  A J Simmers; L S Gray; K Spowart
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

3.  Reading type for children.

Authors:  G M Maclure
Journal:  Br J Ophthalmol       Date:  1980-06       Impact factor: 4.638

4.  Preschool visual acuity screening tests.

Authors:  D S Friendly
Journal:  Trans Am Ophthalmol Soc       Date:  1978
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.